Maternal Cytokine Linked to Offspring's Emotional Behavior, Study Finds
ICARO Media Group
Researchers at Weill Cornell Medicine have made a groundbreaking discovery regarding the impact of maternal immune response on an offspring's psychiatric conditions. The study, published in Brain, Behavior, and Immunity, reveals the critical role of a cytokine called XCL1 in fetal brain development and emotional behavior of male offspring.
Contrary to previous assumptions, the study demonstrates that even low levels of XCL1 circulating in maternal blood during pregnancy play a vital role in regulating fear behavior and ensuring healthy placental development. The temporary spike in maternal XCL1 is found to be crucial for proper placental development and managing fear responses in male offspring.
The researchers observed that disruptions in the levels of this cytokine were linked to increased anxiety and stress reactions in male offspring. Neuronal abnormalities in the ventral hippocampus, a brain region associated with anxiety and anxious behavior, were found when the cytokine spike was blocked or neutralized.
Although the immune and neuronal abnormalities normalized by adulthood, suggesting that the early-life proinflammatory state might be linked to adult anxious behavior in the offspring. These findings shed new light on how maternal immune responses during pregnancy can influence psychiatric conditions in children.
Lead author Dr. Miklos Toth, a professor of pharmacology at Weill Cornell Medicine, explains that XCL1 usually remains at low levels throughout pregnancy, except for a temporary rise and fall in the middle period. This temporary increase is essential for proper placental development and emotional behavior of the offspring.
The study was conducted using a preclinical model and supports previous epidemiological studies suggesting a connection between maternal infection, inflammation during pregnancy, and the development of psychiatric disorders in offspring later in life.
Moving forward, Dr. Toth and his team plan to investigate other chemokines that may also regulate placenta development and impact offspring emotional behavior. Their future collaboration with researchers who have access to blood samples from pregnant women aims to validate the observations made in mouse models.
The study was supported by the National Institute of Mental Health, a part of the National Institutes of Health, with grant R01MH113124 and 1R01MH117004.
Overall, this groundbreaking research provides crucial insights into the role of maternal cytokines in shaping the mental health of offspring and highlights the importance of understanding the complex relationship between maternal immune response and psychiatric conditions in children.